Akmal A. Hameed, MBBS, MD, Suhaila E. Al-Jawder, MD, MRCP, Hassan Mohamed, MD.
hen a patient presents with headache described as" the worst headache of my life," plain CT …

Prophylactic triple-H therapy (the combination of induced hypertension, hypervolemia, and
hemodilution) has been suggested to prevent cerebral vasospasm after subarachnoid …

The combination of induced hypertension, hypervolemia, and hemodilution constitutes triple
H therapy is an option for preventing and treating cerebral vasospasm after aneurysmal …

Cerebral vasospasm is a recognised but poorly understood complication for many patients
who have aneurismal subarachnoid haemorrhage and can lead to delayed ischaemic …

Cerebral vasospasm (CVS) is a common complication following aneurysmal subarachnoid
hemorrhage (SAH), and is the leading cause of death and disability in SAH patients. Till …

Outcome in patients with aneurysmal subarachnoid hemorrhage (SAH) have improved over
the past two decades with advances in neurosurgery and neurocritical care, including an …

Cerebral vasospasm (CVS) is the leading cause of acute focal cerebral ischemia after
subarachnoid hemorrhage (SAH). CVS occurs in about one-third of SAH patients. CVS …

Cerebral vasospasm is the leading cause of disability and death in patients with
spontaneous subarachnoid hemorrhage, and there is no definitive and effective treatment …

✓ In an effort to help clarify the current state of medical therapy for cerebral vasospasm, the
authors reviewed the relevant literature on the established medical therapies used for …

Aneurysmal subarachnoid hemorrhage-(aSAH-) associated vasospasm constitutes a
clinicopathological entity, in which reversible vasculopathy, impaired autoregulatory …